Modern Intensive Care in Sepsis and Septic Shock: Early Recognition, Hemodynamic Resuscitation, and Assessment of Organ Perfusion

Authors

Keywords:

sepsis, septic shock, early recognition, hemodynamic resuscitation, organ perfusion, lactate, capillary refill time, vasopressors

Abstract

Sepsis remains a leading cause of death in intensive care units worldwide, accounting for an estimated 48.9 million cases and 11 million deaths annually. Outcomes depend critically on the speed of recognition and the quality of early hemodynamic resuscitation.

To synthesize current evidence on three pillars of modern intensive care for sepsis and septic shock: early identification, hemodynamic resuscitation, and bedside assessment of organ perfusion.

Narrative review of randomized controlled trials, international guidelines (Surviving Sepsis Campaign 2021), and major observational studies published between 2001 and 2025, identified through PubMed, Scopus, and the Cochrane Library.

Screening instruments (qSOFA, NEWS2, SIRS) each trade sensitivity against specificity, and guidelines now favor sensitive multi-parameter scores supported by lactate measurement and, increasingly, machine-learning surveillance. Resuscitation has shifted from protocolized early goal-directed therapy toward individualized, fluid-conservative strategies: balanced crystalloids, early norepinephrine, adjunctive vasopressin and hydrocortisone in refractory shock, and a default mean arterial pressure target of 65 mm Hg. Perfusion assessment combines serial lactate, capillary refill time, central venous oxygen saturation, the veno-arterial CO2 gap, and point-of-care ultrasound; peripheral perfusion-targeted resuscitation proved at least equivalent to lactate-targeted therapy in ANDROMEDA-SHOCK.

Modern sepsis care is time-critical, individualized, and multimodal. Bundled early recognition, judicious fluids with early vasopressors, and repeated multimodal perfusion assessment form the current standard; artificial intelligence and microcirculation-guided therapy are the most promising frontiers.

References

1. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–810.

2. Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200–211.

3. Seymour CW, Gesten F, Prescott HC, et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med. 2017;376(23):2235–2244.

4. Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181–1247.

5. PRISM Investigators. Early, goal-directed therapy for septic shock — a patient-level meta-analysis. N Engl J Med. 2017;376(23):2223–2234.

6. Hernández G, Ospina-Tascón GA, Damiani LP, et al. Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK randomized clinical trial. JAMA. 2019;321(7):654–664.

7. Cecconi M, De Backer D, Antonelli M, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2014;40(12):1795–1815.

8. Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign bundle: 2018 update. Crit Care Med. 2018;46(6):997–1000.

9. Adams R, Henry KE, Sridharan A, et al. Prospective, multi-site study of patient outcomes after implementation of the TREWS machine learning-based early warning system for sepsis. Nat Med. 2022;28(7):1455–1460.

10. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368–1377.

11. Semler MW, Self WH, Wanderer JP, et al. Balanced crystalloids versus saline in critically ill adults. N Engl J Med. 2018;378(9):829–839.

12. Meyhoff TS, Hjortrup PB, Wetterslev J, et al. Restriction of intravenous fluid in ICU patients with septic shock. N Engl J Med. 2022;386(26):2459–2470.

13. National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network; Shapiro NI, Douglas IS, Brower RG, et al. Early restrictive or liberal fluid management for sepsis-induced hypotension. N Engl J Med. 2023;388(6):499–510.

14. Permpikul C, Tongyoo S, Viarasilpa T, et al. Early use of norepinephrine in septic shock resuscitation (CENSER): a randomized trial. Am J Respir Crit Care Med. 2019;199(9):1097–1105.

15. Annane D, Renault A, Brun-Buisson C, et al. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med. 2018;378(9):809–818.

16. Asfar P, Meziani F, Hamel JF, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370(17):1583–1593.

17. Lamontagne F, Richards-Belle A, Thomas K, et al. Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: a randomized clinical trial. JAMA. 2020;323(10):938–949.

18. Ince C. Hemodynamic coherence and the rationale for monitoring the microcirculation. Crit Care. 2015;19(Suppl 3):S8

Downloads

Published

13.11.2026

Issue

Section

Articles

How to Cite

Khasanov, K. (2026). Modern Intensive Care in Sepsis and Septic Shock: Early Recognition, Hemodynamic Resuscitation, and Assessment of Organ Perfusion. Bulletin of Contemporary Researches, 2(4), 124-130. https://bulconre.com/index.php/mult/article/view/55